pomalidomide has been researched along with Graft vs Host Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baird, K; Berger, A; Cao, L; Comis, LE; Cowen, EW; Curtis, LM; Figg, WD; Gale, RP; Hakim, FT; Holtzman, NG; Joe, GO; Kuzmina, ZJ; Mays, JW; Mitchell, SA; Ostojic, A; Parsons-Wandell, L; Pavletic, SZ; Peer, CJ; Pirsl, F; Pusic, I; Rose, JJ; Venzon, DJ | 1 |
| Lazaryan, A | 1 |
| Elkinson, S; McCormack, PL | 1 |
| Bauer, S; DiPersio, JF; Gale, RP; McFarland, K; Pavletic, SZ; Pusic, I; Rettig, MP | 1 |
| Gahrton, G | 1 |
2 review(s) available for pomalidomide and Graft vs Host Disease
| Article | Year |
|---|---|
Pomalidomide: first global approval.
Topics: Angiogenesis Inhibitors; Animals; Clinical Trials as Topic; Drug Approval; Graft vs Host Disease; Humans; Multiple Myeloma; Thalidomide | 2013 |
Progress in allogeneic transplantation for multiple myeloma.
Topics: Antineoplastic Agents; Cyclophosphamide; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Killer Cells, Natural; Lymphocyte Transfusion; Multiple Myeloma; Thalidomide; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2010 |
2 trial(s) available for pomalidomide and Graft vs Host Disease
| Article | Year |
|---|---|
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Allografts; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Resistance; Fatigue; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Infections; Joints; Kaplan-Meier Estimate; Lymphocyte Count; Lymphocyte Subsets; Lymphopenia; Male; Middle Aged; Quality of Life; Salvage Therapy; Skin; Thalidomide; Young Adult | 2021 |
Phase-1/-2 study of pomalidomide in chronic GvHD.
Topics: Adult; Chronic Disease; Female; Graft vs Host Disease; Humans; Male; Middle Aged; Pilot Projects; Thalidomide | 2016 |
1 other study(ies) available for pomalidomide and Graft vs Host Disease
| Article | Year |
|---|---|
New is forgotten old: IMiDs against chronic GVHD.
Topics: Graft vs Host Disease; Humans; Immunologic Factors; Thalidomide | 2021 |